Memorial Sloan Kettering invests in oncology startup Cota's Series C funding round

Cota completed its Series C investment round with $40 million in funding, the New York City-based healthcare analytics startup confirmed Feb. 21.

IQVIA, a Durham, N.C.-based healthcare technology and contract research services provider, led the funding round with major participation by EW Healthcare Partners, a New York City-based pharmaceutical company focused on oncology.

New York City-based Memorial Sloan Kettering Cancer Center also participated in the funding round, along with a group of existing investors. Memorial Sloan Kettering entered into a multiyear partnership with Cota in November, under which the cancer center will provide the startup with anonymized clinical data.

Cota's leadership team plans to use the Series C funding to scale its solution across healthcare providers, payers and life sciences companies. Cota's solution helps healthcare organizations apply precision medicine by categorizing patient demographic factors, diseases and therapies.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars